Understanding Private Share Placement And The Impact On Share Price

Private Share Placement is one of the most popular processes of raising fresh capital, widely adopted by the private as well as public companies. Under the process, the companies issue its shares to private investors comprising of institutional investors, retail investors like High Net-worth Individuals, banks, mutual funds, insurance companies, at a fixed issue price.

The whole idea behind the concept is to raise funds through the fresh issue of securities to selected private individuals. But this method adversely impacts the ownership of existing shareholders in the company due to dilution. That means that after the company announces secondary issue via placement, the additional shares get added to the outstanding shares of the company which in turn brings down the ownership percentage of existing shareholders.

For instance, if the company had total of 10,000 outstanding shares and a shareholder is holding 1,000 shares of the company, then the private placement of say about 3,000 shares will reduce his ownership proportion 10% to 7.7%.

Prior to share placement 

A shareholder owns = Number of shares held *100/ Total number of company’s outstanding share

                                   = 1,000*100/10,000

                                  = 10% of the total company’s equity.

Post Private Share Placement

That same shareholder will own = 1,000*100/ 13,000

                                                           = 7.7% of the total company’s equity

Consequently, many investors sell-off their shareholding leading to a decline in the share price of the company on the stock exchange. Recently, the pharmaceutical company Creso Pharma Limited (ASX: CPH) announced the placement of A$3.00 million pursuant to which it received A$2.725 million from sophisticated and institutional investors by 31st January 2019. And as the company issued 6,055,556 shares in settlement of placement, its stock price fell straight by 13.68% on ASX, to close at A$0.410 as at 31 January 2019.

But if the investors look at the bright side of the private placement, they can see the benefits emerging in long-run, provided the company invests additional capital in business expansion which boosts the revenue earning potential and financial health of the company.

Another advantage of the private placement is that it provides additional funding at the time the company needs the financial strength to get hold of the outstanding opportunity it comes across. Generally, a private placement is announced at a discounted price compared to its current market price with the view to attract institutional as well as retail investors. But the guidelines and issue price and size of the placement may vary for retail and institutional investors. It gives an opportunity to the company to raise funds from retail investors during sluggish market conditions.

Moreover, the private placement is governed by the minimum regulatory requirement. For public listed companies there are standards prescribed by security exchange to which the company needs to abide by.

The short-term dilution impact to the existing shareholders and share price fluctuation associated with share placement, needs to be carefully considered against the possible long-term benefits.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report